Multiple sclerosis (MS) is an autoimmune disease characterized by immune-mediated inflammation, which attacks the myelin sheath. MS pursues a relapsing and remitting course with varying intervals between symptoms. The main clinical pathological features include inflammation, myelin sheath destruction and plaque formation in the central nervous system (CNS). We previously reported that cystatin F (CysF) expression is induced in demyelinating lesions that are accompanied by active remyelination (referred to as shadow plaques) but is downregulated in chronic demyelinated lesions (plaques) in the spinal cord of MS patients and in several murine models of demyelinating disease. CysF is a cathepsin protease inhibitor whose major target is cathepsin C (CatC), which is co-expressed in demyelinating regions in Plp 4e/À mice, a model of chronic demyelination. Here, we report the time course of CatC and CysF expression and describe the symptoms in a mouse experimental autoimmune encephalomyelitis (EAE) model using CatC knockdown (KD) and CatC over-expression (OE) mice. In myelin oligodendrocyte glycoprotein (MOG)-EAE, CatC positive cells were found to infiltrate the CNS at an early stage prior to any clinical signs, in comparison to WT mice. CysF expression was not observed at this early stage, but appeared later within shadow plaques. CatC expression was found in chronic demyelinated lesions but was not associated with CysF expression, and CatCKD EAE mouse showed delayed demyelination. Whereas, CatCOE in microglia significantly increased severity of demyelination in the MOG-EAE model. Thus, these results demonstrate that CatC plays a major role in MOG-EAE.
Multiple sclerosis (MS) is an immune-mediated disease accompanied by demyelination that affects the CNS, and is the most common cause of serious physical disability in young adults, especially in women. It is believed that the demyelination is caused by an immune system attack, and relapses coincide with focal CNS inflammation and demyelination (Dendrou et al. 2015) . It is thus important to prevent aggravation during the early stages of MS and to elucidate the causes of aggravation.
Experimental autoimmune encephalomyelitis (EAE) is induced by autoimmune reaction against myelin components and is the most commonly used experimental animal models for inflammatory demyelinating disease, such as MS, as it shows similar clinical and histological features (Baker and Jackson 2007; Robinson et al. 2014; Lampron et al. 2015) . However, myelin oligodendrocyte glycoprotein (MOG)-EAE mice gain full recovery over time, which is different from relapse-remitting MS. (McPherson et al. 2014; Nuro-Gyina et al. 2016) . Neuroprotective microglia/macrophage cells are found more than damaging microglia/macrophage cells during the early phase in acute EAE but damaging microglia/macrophage cells become abundant during peak and recovery phase of EAE (Ahn et al. 2012) . Damaging macrophages/microglia usually secrete pro-inflammatory cytokines and neuroprotective macrophages/microglia usually secrete anti-inflammatory cytokines (Martinez et al. 2009; Hind et al. 2016) . Previous studies showed that the microenvironment of severe relapsing EAE prefer polarization to damaging cells and increasing the number of neuroprotective cells would be supportive for the treatment of this disease (Cao and He 2013) .
In previous studies from our group, using the hemizygous proteolipid protein 1 transgenic mouse strain, 4e (plp 4e/À ), a chronic demyelinating model, we showed that cystatin F (CysF) gene expression increases at the acute demyelinating and remyelinating stages but is rapidly decreased when remyelination is impaired in chronic phase (Ma et al. 2007 (Ma et al. , 2011 Shimizu et al. 2017) . CysF is a papain-like lysosomal cysteine proteinase inhibitor, also known as Cst7, cystatin-like metastasis-associated protein and leukocystatin. CysF is selectively expressed in immune cells. The major target of CysF is cathepsin C (CatC), which is a lysosomal cysteine protease also known as Ctsc, DPPI, DPP1, and AI047818 (Hamilton et al. 2008) . The function of CatC is to cleave dipeptides from the amino terminal of various peptides and proteins, and to activate many granule-associated serine proteases that associate with inflammatory and immune response processes, such as neutrophil elastase, the cytotoxic lymphocyte-associated protease, granzymes A and B, and neutrophil-derived cathepsin G (Pham and Ley 1999; Adkison et al. 2002) . A previous study showed that CatC is the primary enzyme that activates neutrophil-derived serine proteases in vivo. These proteases are very important for inflammatory processes, and the CatC deficiency dramatically protected against arthritis development in a model of acute inflammatory arthritis (Adkison et al. 2002; Eyles et al. 2006) .
In our previous study, we found that CysF knockdown (KD) or CatC over-expression (OE) in microglia exacerbate the demyelinating symptoms in plp 4e/À mice (Shimizu et al. 2017) . A similar result was found in a cuprizone-induced demyelination model, where the absence of the CysF gene and the resulting disinhibition of CatC aggravated the demyelination (Liang et al. 2016) . CatC activity can be regulated by various mechanisms and is involved in inflammatory responses (Conus and Simon 2008) ; for example, the absence of the CysF gene increases the activity of CatC and enhances demyelination. These studies demonstrated that CatC and CysF are strongly associated with demyelinating processes including the prevention of demyelination. The plp 4e/À mouse is a useful model for chronic demyelination phase of MS because it has a similar pathology to MS in the late phase. Conversely, plp 4e/À mice are not suitable for studying the acute phase of demyelination because the disease mechanism is different from MS, for example, it occurs without T-cell infiltration. The cuprizone model is also used to study the acute demyelination phase of MS. However, unlike MS, the cuprizone model maintains an intact blood-brain barrier with no T-cell infiltration. Thus, we utilized the MOG-EAE model to study the acute demyelination phase. Here, we investigated the expression patterns of CatC and CysF in the MOG-EAE model using wild type (WT) mice and characterized the symptoms in CatCKD and CatCOE MOG-EAE mice both clinically and histologically. We found that CatC is expressed in demyelinating lesions and that CysF is expressed in shadow plaques of MOG-EAE WT mice spinal cord. CatC was expressed in the chronic demyelinating area where myelin is completely lost. Conversely, CysF was expressed in the area surrounding the chronic demyelinated area. We also found that CatC plays a role in aggravating the symptoms in MOG-EAE. These results suggest that CatC is a potential target for suppressing the progression of demyelination during the early phase of EAE.
Materials and methods

Experimental animals
The Neo STOP-tetO insertion cassette containing 10 kb of the targeting vector (3 0 homology arm), 1.8 kb of Neo STOP-tetO cassette (5 0 homology arm) and diphtheria toxin A was inserted upstream of CatC translation initiation site (Shimizu et al. 2017) . The C57BL/6N ES cell line RENKA (Mishina and Sakimura 2007) was used for the recombination. The CatC STOPtetO mouse line (generated using the FAST system) and Iba1-tTA mouse line 75 (initial BDF1 background backcrossed to C57BL/6 background; Tanaka et al. 2012) ; CatCKD) and C57BL/6N (Charles River, Yokohama, Japan, C57BL/6NCrl) mice were used in this study (Tanaka et al. 2010; Shimizu et al. 2017 All animal procedures were conducted in accordance with the guidelines described in the National Institutes of Health Guide for the care and use of laboratory animals, and by the National Institute for Physiological Sciences Animal Care and Use Committee (approval # 10A250). All efforts were made to minimize distress and pain. The generation of STOPtetO mice was conducted in accordance to the animal welfare committees and the ethics committees of Niigata University guideline. All animals were kept on a 12 : 12 h light/dark cycle housed with no more than four adult mice per cage with food and water available ad libitum.
Myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis (MOG-EAE) Mice (n = 55; age 7-10 weeks) weighing between 18 and 22 g were used for this experiment. The overview of the study design is described in Fig. 1 . Mice of both sexes were used in this study. The study was not pre-registered. No randomization procedures nor sample size calculation were performed in this study. The MOG 35-55 peptide; MEVGWYRSPFSRVVHLYRNGK (150 lg; Custom made, Peptide Institute Inc., Osaka, Japan) was emulsified in complete Freund's adjuvant (CFA; Sigma-Aldrich, St. Louis, MO, USA, F5581) consisting with 1 : 1 ratio of incomplete Freund's adjuvant (IFA; Sigma-Aldrich, F5506) and Mycobacterium tuberculosis 4 mg/mL (Difco Laboratories, Detroit, MI, USA, 231141). Mice were subcutaneously immunized with MOG/CFA into two sites of dorsal flank followed by an intraperitoneal injection with pertussis toxin (400 ng; List Biological Labs, Inc., Campbell, CA, USA, #180) at day 0 (immediately after immunization) and day 2 (48 h later). The WT MOG EAE mice were observed daily and tissues collected at 1, 2, 3, 4, and 6 weeks after immunization for analysis (n = 3 per each group, total n = 15 mice; Fig. 2a ). Transgenic mice (CatCKD, CatCOE, and WT) were monitored daily until day 14, but some mice were killed earlier to collect tissue for analysis (Fig. 1) . The samples for tissue analysis were collected at the beginning of EAE on day 10 (n = 9), day 12 (n = 9), and peak EAE on day 14 (n = 22) after immunization (total n = 40 mice).
The clinical phenotype of EAE was monitored daily and given a clinical score: clinical score range from 0 to 5 and are based on disease severity: 0, no clinical signs; 1, limp tail; 1.5, impaired righting reflex and limp tail; 2, limp tail and weakness in hindlimbs; 2.5, limp tail and paralyzed one of the hindlimbs; 3, paralyzed both hindlimbs or one side of forelimb and hindlimb or the combination of all of the following symptoms -spinning when picked up by the tail, severe head tilting, walking by pushing body along edges against to the cage wall; 3.5, completely paralyzed both of hindlimbs; 4, completely paralyzed of both hindlimbs and one forelimb; 5, complete quadriplegia, moribund or death of the animal. In addition, any animals that reached the peak of EAE pathology and died were given a score of five.
Experimental lists of genotypes were blinded during the investigation to minimize potential bias. Mice also were observed for pain and discomfort signs from EAE during daily monitoring (abnormal appearance, altered behavior, vocalization, mutilation, and inappetence). Those mice which suffered from EAE clinical phenotype were separated and granted easier access to water and food. Mice that reached a moribund stage and are moribund with EAE should be killed for humane reasons. The data should be excluded if mice showed no clinical phenotype (score 0), indicating unsuccessful MOG-EAE, or were sick/moribund without any EAE-related clinical phenotype. No mice were excluded in this study based on the described exclusion criteria. No pain medications were applied in this study.
Mouse tissue preparation
Mice were anesthetized by intraperitoneal injection of chloral hydrate and anesthesia result was assessed by the complete depression of palpebral and pedal reflexes. Mice were perfused with phosphatebuffered saline (PBS), followed by 4% paraformaldehyde (PFA) in PBS through cardiac puncture. Brains and thoracic spinal cords were dissected out and post-fixed in the same fixative overnight. The tissues were then cryoprotected with PBS containing 20% sucrose overnight and embedded in OCT compound (Sakura Finetek Co., Tokyo, Japan, 4583). Sections were cut at a thickness of 20 lm with a cryostat (Leica CM3050, Germany).
In situ hybridization
Frozen sections of spinal cord that had been perfused with 4% PFA were used. These were post-fixed for 20 min in 4% PFA, washed with PBS twice for 5 min, and treated for 30 min with 20 lg/mL proteinase K. To inactivate proteinases, sections were briefly washed with PBS and then fixed with 4% PFA for 15 min. Sections were further washed with 0.1 M triethanolamine-HCl for 15 min and washed with PBS twice for 5 min. Pre-hybridization was carried out for 2-4 h at 65°C in hybridization buffer (59 saline-sodium citrate, 50% formamide, 200 lg/mL heparin and 0.2 mg/mL yeast tRNA). Hybridization was conducted at 65°C overnight. Hybridization buffer contained 300 ng/mL digoxigenin labeled cRNA probe. Sections were washed with saline-sodium citrate and blocked with blocking buffer followed by alkaline phosphatase conjugated antidigoxigenin antibody incubation at 20-25°C for 60 min. Un-bound antibody was removed by washing with maleic acid buffer containing Tween 20 (MABT) solution (100 mM maleic acid, 150 mM NaCl, 0.1% Tween20, pH 7.5) for 30 min, 3 times. Nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) (Roche diagnostics, Germany, 11681451001) was used to develop color for up to 24 h and then NBT/BCIP reaction stopped by washing remaining solution with PBS. Nuclear Fast Red (Vector Lab, Burlingame, CA, USA, H-3403) was used as counterstaining solution. The Olympus digital camera system (DP70) in combination with an Olympus BX51 microscope was used to capture images.
Immunohistochemical analysis
Frozen sections of spinal cord that had been perfused with 4% PFA were used. Washing the thoracic spinal cord cryosections with PBS for 5 min was followed by antigen retrieval with citrate buffer. Tissue slides were treated with citrate buffer 10 mM (pH 6.0) and heated in a microwave oven (550W) for 3 min, then sections were left until they cooled down. The sections were treated with 0.03% H 2 O 2 in 0.1% Triton-9100 PBS-T for 30 min and washed with PBS 3 times for 5 min. Normal goat serum (10%) in PBS-T was used as blocking agent to reduce non-specific binding. The sections were blocked at 20-25°C for 60 min, followed by primary antibodies incubation at 4°C overnight. After washing with PBS three times, sections were incubated with secondary antibodies at 20-25°C for 60 min, washed with PBS-T three times for 5 min and then incubated with horseradish peroxidase streptavidin biotin complex or ABC solution (Vector Laboratories, Burlingame, CA, USA, PK-4000; RRID:AB_2336818). The color development was performed with 3,3 0 -diaminobenzidine solution (Vector laboratories, Burlingame, CA, USA, SK-4100; RRID:AB_2336382) with 0.03% H 2 O 2 . The sections were dehydrated with ethanol in 70%, 80%, 90%, 100% serial concentrations, respectively. The sections were cleared with Clear Plus and were mounted with Permount solution. The Olympus digital camera system (DP70) in combination with an Olympus BX51 microscope was used for capturing images. The following antibodies were used; rabbit polyclonal antiIba1 antibody (1 : 1000; Wako, Osaka, Japan; RRID: and 6 weeks after immunization for pilot experiment and 10, 12 and 14 days after immunization for transgenic mice group experiment. Clinical sign was monitored daily. Fig. 2 CatC, CysF and c-fms mRNA expression patterns throughout the course of EAE. The experimental design of MOG-EAE induced paralysis (a). The expression of CatC (B1-F1), CysF (B2-F2) and c-fms (B3-F3) mRNA was examined in MOG-EAE-induced wild-type mice at 1, 2, 3, 4 and 6 weeks (a-e) after immunization with MOG peptide (n = 3 per group). in situ hybridization (ISH) was performed on spinal cord sections at the thoracic level using probes for CatC, CysF, and cfms (for microglial activation) and IHC was performed using a rat monoclonal anti-proteolipid protein (PLP) antibody for myelin staining (B4-F4; outlined with red dash line). Clinical signs were observed daily after immunization and a clinical score was recorded: 0 = normal, 1 = limp tail, 2 = hind leg weakness, 3 = paralysis in both hind legs, 4 = complete paralysis in both hind legs and paralysis in one front leg, 5 = moribund or death. The percentage of the demyelinating area was quantified by densitometric analysis using the Image J program and differences between groups are shown graphed (g). Values represent the mean AE SEM. A one-way ANOVA test plus Bonferroni's post hoc test were performed for statistical analysis (*p < 0.05, **p < 0.01, ***p < 0.001 compared between each group). Scale bars: b-f, 200 lm. For immunofluorescence, cryosections from spinal cords perfused with 4% PFA were used. The sections were briefly washed with PBS for 5 min, followed by antigen retrieval process and then washed again with PBS (3 times for 5 min). The sections were blocked with blocking agent to reduce non-specific binding at 20-25°C for 60 min, followed by primary antibody incubation at 4°C overnight. Appropriate Alexa-conjugated secondary antibodies; Alexa 568-conjugated anti-mouse IgG (Invitrogen; RRID: AB_141611) and Alexa 568-conjugated anti-rat IgG (Invitrogen; RRID:AB_141874) were used.
Electron microscopy
Mice were perfused with fixative solution which contained 2.5% (v/ v) glutaraldehyde and 2.0% (w/v) PFA in 0.1 M cacodylate buffer (pH 7.4) into mouse circulation through the left ventricle. Spinal cord were immersed in the fixative solution for a couple of days at 4°C, then 0.5 mm thick cross-sectional slices of spinal cord were prepared with a razor blade and 2 mm 9 1.5 mm blocks were further processed for electron microscopy.
The specimens were immersed in 1% (w/v) osmium tetroxide solution for 2 h at 4°C, followed by dehydration process through a graded alcohol series and embedded in Epon 812 resin (TAAB Laboratories, Aldermaston, UK, T022). The specimens were collected for 1 lm semithin section, stained with toluidine blue 0.5% (w/v) in 0.1 M PB and images were captured with an Olympus light microscope equipped with an auto-digitizer to generate 'virtual slides' (NanoZoomer-RS, Hamamatsu Photonics). The ultrathin sections were collected for whole area EM analysis of the same specimens by ultra-microtome (Ultracut UCT, Leica, Germany) without trimming on platinum-coated glass slides, stained with uranyl acetate and lead citrate. The specimen grids were imaged with a scanning electron microscope equipped with a back-scattered electron beam detector (SU8010, Hitachi, Japan) at 1.5 KV accelerating voltage. From each section, a digitized image with an area of about 200 lm by 300 lm was captured at a resolution of 24.8 nm/pixel.
Image and statistical analysis
The total myelin stained areas were quantified by densitometric analysis with Image J program (National Institutes of Health, Bethesda, MD, USA; RRID:SCR_003070). Data were represented in the mean AE SEM. The significance was assessed by an unpaired two-tailed Student's t-test, one-way or two-way analysis of variance (ANOVA) followed by a Bonferroni test using the scientific statistics software Graphpad Prism version 5.0b (GraphPad Software, Inc., La Jolla, CA, USA; RRID:SCR_002798). p-values were considered significant when less than 0.05. The test for outliers was not conduct on the data.
Results
CatC and CysF expression patterns in the spinal cord of MOG-EAE mice at different time points
In previous studies using Plp 4e/À mice, a chronic demyelination model, CatC and CysF expression were demonstrated in specific patterns; CysF dominated CatC during the remyelination, then CatC dominated CysF during the chronic demyelinaton. However, Plp 4e/À mice and cuprizone model mice do not show inflammation associated with T-cell infiltration, which is a critical difference from the acute phase of MS. Thus, MOG-EAE was chosen as a model to study inflammatory demyelination in early phase because of the similarities with early phase MS. CatC and CysF expression was examined in the spinal cord of MOG-EAE mice. We generated the MOG-EAE model using WT mice and observed the distribution of CysF and CatC mRNA in the spinal cord at 1, 2, 3, 4, and 6 weeks after immunization (Fig. 2a) . MOG-EAE mice were observed for clinical signs every day after immunization and were recorded as clinical scores until the day of sacrifice.
One week after immunization (Fig. 2b) , mice showed no clinical signs (clinical score = 0) and demyelination was not found in the spinal cord (Fig. 2b4) . Surprisingly, CatC mRNA-positive cells were found in the gray matter and white matter, and were found infiltrated into the anterior median fissure of the spinal cord (Fig. 2b1) where c-fms mRNApositive cells were accumulated (Fig. 2b3) . In contrast, CysF mRNA-positive cells were not found at this stage (Fig. 2b2) . Two weeks after immunization (Fig. 2c) , mice started to show clinical signs, including a limp tail and gradual progressive weakness of the hindlimbs and a disturbance of the righting reflex (clinical score = 2/3). At this stage, demyelinating lesions were observed based on proteolipid protein immunostaining (Fig. 2c4 , area surrounded by the broken red line). The accumulation of more CatC and c-fms mRNA-positive cells were observed in the demyelinating area ( Fig. 2c1 and 3 ), whereas few CysF mRNA-positive cells were found at the demyelinating area edge, where myelin remained. Three to 4 weeks after immunization (Fig. 2d-e) , many demyelinating lesions were clearly shown, and mice established severe clinical signs (clinical score = 3/4), including paralysis in both hindlimbs. CatC and c-fms mRNA-positive cells were found aggregated largely in the demyelinating and surrounding areas. CysF expression remained at weak levels and CysF-positive cells were only observed in the shadow plaques. Clinical scores gradually declined 6 weeks after immunization. At this stage, demyelinating lesions became smaller (Fig. 2f4) and CatC and c-fms-positive cells were found only in a small region of spinal cord, where demyelination is observed (Fig. 2f1 and 3) . CysF mRNA-positive cells were distributed in a similar pattern to that of CatC-positive cells, although it was only found in the shadow plaques (Fig. 2f2) . The percentage of demyelinated area in spinal cord increased over time after immunization, which started at 2 weeks after immunization (Fig. 2g) . The percentage of the demyelinating area at 4 weeks after immunization significantly increased (4.35 AE 0.71%; n = 3) compared to that of 1 week after immunization group (0%; n = 3) (p < 0.001), 2 weeks after immunization group (1.82 AE 0.42%; n = 3) (p < 0.05), however, no significant difference was found when compared to 3 weeks after immunization group (2.99% AE 0.32%; n = 3). The percentage of the demyelinating area at 6 weeks after immunization significantly decreased (1.16 AE 0.13%; n = 3) (p < 0.01) compared to that of 4 weeks after immunization group.
We found CatC mRNA-positive infiltrating cells in the anterior median fissure during the very early phase (the 1st week after immunization) of MOG-EAE when there are no obvious demyelinating lesions nor physical signs. CatC mRNA-positive infiltrating cells were found in the white matter through the end of the observation period 6 weeks after immunization. CysF mRNA-positive cells were found later than CatC-positive cells in the shadow plaques.
To identify the cell types expressing CatC mRNA during the early stage, MOG-EAE mice were examined at 1 week after immunization. The results showed that the CatC mRNA-positive cells in the anterior gray horn of the spinal cord were microglia, and not infiltrating T cells (Fig. 3a and  c) . The CatC mRNA-positive cells, which infiltrated at the anterior median fissure may associated with hematopoietic cell lineages which crossed the blood-brain barrier after triggering an immune reaction caused by EAE. The infiltrating cells type was identified as polymorphonuclear based on cell morphology, which identifies them as neutrophil granulocytes (Fig. 3d) . CatC in situ hybridization (ISH) showed that most of the cells at the median anterior fissure of the spinal cord were CatC mRNA-positive (Fig. 3b) . In summary, CatC mRNA-positive cells were found in the microglia at the anterior gray horn and in the infiltrating cells (including neutrophils) at the anterior median fissure of the spinal cord.
Expression of CatC and CysF mRNA in regions of degenerated myelin Myelin debris phagocytosis in acute MS lesions by microglia and macrophages is well studied, and the immune system is the primary mechanism that is used to remove cell debris and pathogens (Liu et al. 2006) . CatC mRNA-positive cells were the only cells that were observed to be infiltrating the CNS prior to triggering myelin damage by an immune attack in the early phase of EAE. However, we did not find any CysF involvement in this phase (Fig. 2) . CatC and CysF expression was also observed at a later stage of EAE, when immune attack induced myelin degeneration and myelin debris phagocytosis that was labeled by galectin 3 (Gal3) ISH (Sano et al. 2003) (Fig. 4a) . The demyelinated lesions were found after 2 weeks of immunization (Fig. 4b) . CatC and Gal3 mRNA-expressing cells were also found in the demyelinated area of the anterior funiculus (Fig. 4a, b , and c). Weaker CysF ISH signals were found in the chronic demyelinated region (Fig. 4d) . These results suggest that CatC plays a role during microglia/macrophages phagocytosed myelin sheaths. Moreover, this also suggests that CysF plays a lesser role in the late inflammatory demyelinating phase of MOG-EAE, as CysFexpression was much lower than CatC in the mid-stage of inflammation in MOG-EAE, when mice showed severe physical signs (clinical score 3, 4, and 5).
Neuroprotective and damaging microglial polarization in MOG-EAE inflammatory demyelination Macrophage/microglial polarization, which consists of proinflammatory damaging (M1) or anti-inflammatory neuroprotective (M2) subtypes, plays a central role in the response to spinal cord inflammation. Previous studies showed that neuroprotective polarization appeared in injured spinal cord microenvironment, in which damaging macrophages transiently appeared only in an early stage after injury (David and Kroner 2011) . Neuroprotective and damaging macrophage/microglial cells were observed in MOG-EAE mice. Thoracic spinal cord sections from the WT mice were analyzed 6 weeks after immunization for the expression of neuroprotective or damaging macrophage/microglial markers in cells of the demyelinating lesions. Damaging cells were found to aggregate in the demyelinating regions (Fig. 5a-c) but only a small number of neuroprotective macrophage/ microglial cells were observed ( Fig. 5d-f ).
CatC plays a role during the early phase of the inflammatory demyelinating model We discovered that the Plp1-over-expressing mouse line (Plp
) and cuprizone mouse model showed worsened symptoms in our previous studies when CysF expression was eliminated, indicating that CysF has supporting role in the demyelinating mouse models which do not show hematopoietic cell infiltration in the lesions (Liang et al. 2016; Shimizu et al. 2017) . In that previous study, the balance between CatC and CysF expression was shown to be essential for myelin regeneration maintenance in both the early and chronic phase of Plp 4e/À mice. In conclusion, CatC might also have an essential part in demyelinating or myelin regenerating processes during the early immune attacking stage in MOG-EAE. To examine the role of CatC, cathepsin C knockdown (CatCKD) and WT mice were used for MOG-EAE. The clinical scores of MOG-EAE CatCKD mice were significantly lower than those of WT mice 10 and 11 days after the immunization (Fig. 6a) , suggesting that CatC expression is toxic to the mice during MOG-EAE. To confirm this, cathepsin C-over-expressing (Cat-COE) and WT mice were used for MOG-EAE. The clinical scores of CatCOE mice were significantly higher than for (CatCOE) and WT mice (b), in which MOG-EAE was induced and animals were killed 2 weeks after immunization, was measured daily after immunization and recorded: 0 = normal, 1 = limp tail, 2 = hind leg weakness, 3 = paralysis in both hind legs, 4 = complete paralysis in both hind legs and paralysis in one front leg, 5 = moribund or death. Six independent experiments were performed with a total number of 13 CatCKD, 12 CatCOE and 15 WT animals to obtain clinical score at the various time points. Values represent the mean AE SEM. A twoWay ANOVA test plus Bonferroni's post hoc test were performed for statistical analysis (*p < 0.05, **p < 0.01, ***p < 0.001 compared to the control group).
WT mice between the 7th and 14th days after immunization (Fig. 6b) . CatCKD, CatCOE, and WT mice were further analyzed histologically at 2 weeks after immunization. CatCOE mice and the WT mice appeared to have similar expression pattern of CatC mRNA-positive cells, which were found to infiltrate the CNS (Fig. 7a1-c1) . The low levels of CysF mRNApositive cells were observed around demyelinating area (Fig. 7a2-c2 ). The activated microglial, which were labeled by c-fms mRNA signals was observed in the demyelinating region ( Fig. 7a3-c3 ). CatCOE EAE mice showed a significantly larger demyelinating area than the control group; conversely, CatCKD EAE mice showed a significant decreased demyelinating area compared to the control group (Fig. 7a4-c4, 7d) Fig. 7 CatC gene manipulation affects demyelination after MOG-EAE. MOG-EAE was induced in CatCKD (n = 3) (a), CatCOE (n = 4) (b) and wild-type (n = 4) (c) mice, and animals were killed 2 weeks after immunization. Spinal cord sections at the thoracic level were analyzed by in situ hybridization (ISH) using probes for CatC, CysF or c-fms (for microglial activation), and by IHC using a rat monoclonal anti-proteolipid protein (PLP) antibody for myelin staining (outlined with red dash line). The percentage of the demyelinating area was quantified by densitometric analysis using the Image J program and differences between groups are shown graphed (d). Values represent the mean AE SEM. An unpaired two-tailed Student's t-test was performed for statistical analysis (*p < 0.05 compared with the control group). Scale bars: a-c, 200 lm. n = 4) compared to that of the control (2.88 AE 0.49%; n = 4) group (p = 0.0492). However, no significant difference was found between CatCKD (1.18 AE 0.38%; n = 3), and WT EAE mice (p = 0.0512). These results are consistent with previous data using Plp 4e/À and cuprizone model mice (Liang et al. 2016; Shimizu et al. 2017) , suggesting that CatC plays a role during the early stage of inflammatory demyelinating disease.
Representative electron micrographs of thoracic spinal cords from CatCOE, CatCKD, and WT MOG-EAE mice were observed 12 days after immunization (Fig. 8) . The CatCOE EAE mice showed multinuclear cells (neutrophils) invading into the white matter of the spinal cord ( Fig. 8c and  f) . However, these cells were not found in CatCKD EAE ( Fig. 8b and e) or WT EAE mice ( Fig. 8a and d) . The number of the multinuclear invading cells in CatCOE mice significantly increased (7 AE 1.15%; n = 3) (p < 0.001) when compared to that of CatCKD (0; n = 3) and WT EAE (0; n = 3) (Fig. 8g) .
Discussion
In this study, using the MOG-EAE model, CatC was demonstrated to play an important role in inflammatory demyelination. First, CatC-expressing cells, which include neutrophils and microglia, infiltrate the CNS during EAE in the early stage, prior to the observation of any clinical signs. Previous studies indicated that the neutrophils, which are one of the inflammatory cells was significantly increased during the disease onset and initiate EAE. These suggest that neutrophils play an important role in EAE pathogenesis and may contribute to demyelinating process in EAE acute phase (Wu et al. 2010; Nemeth et al. 2016) . Neutrophils also have role to assist the blood-brain barrier breakdown, combined with T cells, resulting in influx of inflammatory cells and cause myelin damage (Sayed et al. 2010) . CatC activates some proteases such as cathepsin G (CatG), proteinase 3 (PR3) neutrophil-derived serine proteases and neutrophil elastase (NE), which are specifically found in mature neutrophils, and plays an essential role in inflammation (Adkison et al. 2002) . Neutrophils are also shown to be a source of CatC secretion during inflammatory processes (Hamon et al. 2016) . Moreover, CatC is mostly found in activated microglial cells throughout the brain in early phase of neuroinflammation, which is induced by lipopolysaccharide (Fan et al. 2012) . These evidences propose that CatC is one of the factors in the progression of neuroinflammation and develop demyelination in the CNS. CatC-CysF were shown to prolong expression along the demyelination process in MOG-EAE. CatC was found in chronic demyelinated regions, where the myelin regenerating process has ceased; in contrast, CysF was found at the demyelinated lesion edge, where myelin remained intact. CatC is one of the two genes out of 12,000 that were found to be constantly upregulated during the first couple weeks of MOG-EAE (Mix et al. 2004) . T lymphocytes, the mediators of EAE, enter the CNS parenchyma, which is the critical early event in the immune-mediated illnesses pathogenesis (Zamvil and Steinman 1990; Flach et al. 2016) . CatC is involved in the granzyme processing, which is a neutral serine protease specifically found in activated cytotoxic lymphocytes granules (Kummer et al. 1996; Pham and Ley 1999) . Active forms of granzyme will activate several downstream cascades, such as pro-inflammatory cytokines TNF-a and IL-1b induction or cell death pathway (Shresta et al. 1999; Garcia-Laorden et al. 2016) . The pro-inflammatory damaging (M1) macrophages, induced by TNFa, were present in the chronic demyelinated region and correlated with CatC expression (Sindrilaru et al. 2011) . CatC may promote neurodegenerative (M1) polarization, which causes inhibition of regeneration process in myelin sheath (David and Kroner 2011) . Reducing the cytokine levels and other factors in the damaged spinal cord microenvironment responsible for prolonged or excessed neurodegenerative are likely a promising therapeutic target.
A similar CysF mRNA-expression pattern was found in the chronic demyelination model, Plp 4e/À mouse, as in the EAE mouse model: expression decreased when remyelination was severely affected at age 8 months (Shimizu et al. 2017) . CysF was identified as an ongoing remyelination indicator in various demyelinating models (Ma et al. 2011) . The result from MOG-EAE induction in CatCKD and CatCOE mice in this study confirmed that CatC and CysF are strongly associated with inflammatory demyelination. The severity of EAE was reduced in the absence of CatC, whereas increased microglial CatC expression enhanced clinical severity . These results strongly propose that the interaction of CatC-CysF plays an essential role in the inflammatory demyelination pathogenesis of EAE.
EAE is most commonly used animal model for MS and other demyelinating diseases. The possible role of CatC and CysF in the inflammatory demyelination model was examined in this study. The discovery of a CatC and CysF system might be key to develop new treatments in the future.
